New Fat-Melting injection for double chin enters human testing

NCT ID NCT06756490

Recruiting now Symptom relief Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Mar 14, 2026 · Last updated May 22, 2026 · Updated 13 times

Summary

This early-stage study tests a new drug called HY-2003, which is injected under the chin to reduce excess fat (double chin). About 30 adults with moderate to severe submental fullness will receive either the new drug, a similar approved drug, or a placebo. The main goal is to check safety and side effects, with a secondary look at how well it works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE OR SEVERE SUBMENTAL FULLNESS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Peking Union Medical College Hospital
RECRUITING

Beijing, Beijing Municipality, 100730, China

Contact Email: •••••@•••••
The First Affiliated Hospital of Xi'an Jiaotong University
RECRUITING

Xi'an, Shaanxi, 710061, China

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MODERATE OR SEVERE SUBMENTAL FULLNESS